CARCIK-CD19
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CARCIK-CD19, covering 2023-05-06 to 2024-05-03. Get the full timeline:
Most recent: Clinical Trial Update: Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia [Phase 1, Phase 2]